PMC:7306567 / 8456-8710 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"81","span":{"begin":224,"end":235},"obj":"Chemical"},{"id":"82","span":{"begin":239,"end":248},"obj":"Chemical"}],"attributes":[{"id":"A81","pred":"tao:has_database_id","subj":"81","obj":"MESH:D053139"},{"id":"A82","pred":"tao:has_database_id","subj":"82","obj":"MESH:D053243"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Other factors that might contribute to regional differences in IAPA rates include influenza vaccination rates, with different policies in different countries, and differences in influenza antiviral treatment strategies with oseltamivir or zanamivir [27]."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T48","span":{"begin":82,"end":91},"obj":"Disease"},{"id":"T49","span":{"begin":178,"end":187},"obj":"Disease"}],"attributes":[{"id":"A48","pred":"mondo_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"},{"id":"A49","pred":"mondo_id","subj":"T49","obj":"http://purl.obolibrary.org/obo/MONDO_0005812"}],"text":"Other factors that might contribute to regional differences in IAPA rates include influenza vaccination rates, with different policies in different countries, and differences in influenza antiviral treatment strategies with oseltamivir or zanamivir [27]."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T54","span":{"begin":250,"end":252},"obj":"http://purl.obolibrary.org/obo/CLO_0050509"}],"text":"Other factors that might contribute to regional differences in IAPA rates include influenza vaccination rates, with different policies in different countries, and differences in influenza antiviral treatment strategies with oseltamivir or zanamivir [27]."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T38","span":{"begin":188,"end":197},"obj":"Chemical"},{"id":"T39","span":{"begin":224,"end":235},"obj":"Chemical"},{"id":"T40","span":{"begin":239,"end":248},"obj":"Chemical"}],"attributes":[{"id":"A38","pred":"chebi_id","subj":"T38","obj":"http://purl.obolibrary.org/obo/CHEBI_22587"},{"id":"A39","pred":"chebi_id","subj":"T39","obj":"http://purl.obolibrary.org/obo/CHEBI_7798"},{"id":"A40","pred":"chebi_id","subj":"T40","obj":"http://purl.obolibrary.org/obo/CHEBI_50663"}],"text":"Other factors that might contribute to regional differences in IAPA rates include influenza vaccination rates, with different policies in different countries, and differences in influenza antiviral treatment strategies with oseltamivir or zanamivir [27]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T56","span":{"begin":0,"end":254},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Other factors that might contribute to regional differences in IAPA rates include influenza vaccination rates, with different policies in different countries, and differences in influenza antiviral treatment strategies with oseltamivir or zanamivir [27]."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T52","span":{"begin":224,"end":235},"obj":"CHEBI:7798;CHEBI:7798"},{"id":"T53","span":{"begin":239,"end":248},"obj":"CHEBI:50663;CHEBI:50663"},{"id":"T34533","span":{"begin":224,"end":235},"obj":"CHEBI:7798;CHEBI:7798"},{"id":"T94297","span":{"begin":239,"end":248},"obj":"CHEBI:50663;CHEBI:50663"}],"text":"Other factors that might contribute to regional differences in IAPA rates include influenza vaccination rates, with different policies in different countries, and differences in influenza antiviral treatment strategies with oseltamivir or zanamivir [27]."}

{"project":"2_test","denotations":[{"id":"32572532-31169040-47963415","span":{"begin":250,"end":252},"obj":"31169040"},{"id":"T29746","span":{"begin":250,"end":252},"obj":"31169040"}],"text":"Other factors that might contribute to regional differences in IAPA rates include influenza vaccination rates, with different policies in different countries, and differences in influenza antiviral treatment strategies with oseltamivir or zanamivir [27]."}